Herborium Group Inc
Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The company offers dermatology products, which include AcnEase, an herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for… Read more
Herborium Group Inc (HBRM) - Total Assets
Latest total assets as of August 2025: $150.20K USD
Based on the latest financial reports, Herborium Group Inc (HBRM) holds total assets worth $150.20K USD as of August 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Herborium Group Inc - Total Assets Trend (1998–2024)
This chart illustrates how Herborium Group Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Herborium Group Inc - Asset Composition Analysis
Current Asset Composition (November 2024)
Herborium Group Inc's total assets of $150.20K consist of 18.3% current assets and 81.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.5% |
| Accounts Receivable | $6.50K | 4.1% |
| Inventory | $12.00K | 7.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $128.45K | 81.7% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1998–2024)
This chart illustrates how Herborium Group Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Herborium Group Inc's current assets represent 18.3% of total assets in 2024, a decrease from 80.0% in 1998.
- Cash Position: Cash and equivalents constituted 6.5% of total assets in 2024, down from 15.2% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 81.0% of total assets, an increase from 0.0% in 1998.
- Asset Diversification: The largest asset category is intangible assets at 81.7% of total assets.
Herborium Group Inc Competitors by Total Assets
Key competitors of Herborium Group Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Herborium Group Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Herborium Group Inc generates 6.69x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Herborium Group Inc is currently not profitable relative to its asset base.
Herborium Group Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.01 | 0.01 | 0.20 |
| Quick Ratio | 0.01 | 0.00 | 0.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-2.70 Million | $ -3.76 Million | $ -202.60K |
Herborium Group Inc - Advanced Valuation Insights
This section examines the relationship between Herborium Group Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 0.6% |
| Total Assets | $157.20K |
| Market Capitalization | $0.95 USD |
Valuation Analysis
Below Book Valuation: The market values Herborium Group Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Herborium Group Inc's assets grew by 0.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Herborium Group Inc (1998–2024)
The table below shows the annual total assets of Herborium Group Inc from 1998 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-11-30 | $157.20K | +0.58% |
| 2023-11-30 | $156.30K | -10.74% |
| 2022-11-30 | $175.10K | +3.00% |
| 2021-11-30 | $170.00K | -17.68% |
| 2020-11-30 | $206.50K | +19.36% |
| 2019-11-30 | $173.00K | -24.65% |
| 2018-11-30 | $229.60K | +22.39% |
| 2017-11-30 | $187.60K | +8.19% |
| 2016-11-30 | $173.40K | -11.53% |
| 2015-11-30 | $196.00K | -16.60% |
| 2014-11-30 | $235.00K | +176.15% |
| 2011-11-30 | $85.10K | -8.00% |
| 2010-11-30 | $92.50K | -11.90% |
| 2009-11-30 | $105.00K | -28.57% |
| 2008-11-30 | $147.00K | +87.14% |
| 2007-11-30 | $78.55K | -33.60% |
| 2006-11-30 | $118.30K | -93.92% |
| 2005-11-30 | $1.95 Million | -83.43% |
| 2004-11-30 | $11.74 Million | -20.52% |
| 2003-11-30 | $14.77 Million | -14.45% |
| 2002-11-30 | $17.27 Million | -0.32% |
| 2001-11-30 | $17.32 Million | -16.96% |
| 2000-11-30 | $20.86 Million | +0.83% |
| 1999-11-30 | $20.69 Million | -1.99% |
| 1998-11-30 | $21.11 Million | -- |